ArticlePLoS neglected tropical diseases2025
Molecular characterization of zinc metalloproteinase Nas-14 from Trichinella spiralis and its participation in intestinal invasion.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Aspartic protease 2 from Trichinella spiralis excretion/secretion products hydrolyzes tight junctions of intestinal epithelial cells.PLoS neglected tropical diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Astacins, a family of zinc metalloproteinases, are involved in invasion and tissue migration processes in a variety of parasites. An astacin-like proteinases have been detected in the excretory-secretory products (ESPs) of Trichinella spiralis (T. spiralis), zinc metalloproteinase Nas-14 (TsNas14), but its function in T. spiralis remains unclear. The primary objective of this research was to delineate the molecular characterization of TsNas14 and explore its potential to compromise the integrity of the intestinal barrier. Results showed that TsNas14 contains an Astacin domain and two ShK domains. It is highly conserved and has a consistent transcriptional expression pattern in the Trichinella genus. Quantitative results showed that the TsNas14 is transcribed and expressed during the whole life cycle, but that the expression level was highest in the adult worm (AW) stage. In the 3d AW stage, TsNas14 is mainly distributed on the stichosome, ovary, cuticle, and hypodermis, while in the 6d AW stage, it is only present on the cuticle. Gelatin zymography showed that the oligomerized rTsNas14 had the enzyme activity to degrade gelatin, and could be effectively inhibited by 1,10-Phenanthroline, indicating that it had the natural activity of metalloproteinases. In vitro experiments showed that rTsNas14 can down-regulate the expression of occludin and claudin-1 proteins of human colorectal adenocarcinoma (Caco-2) cells and improve the permeability of an intestinal barrier model. In addition, the direct incubation of rTsNas14 with claduin-1 showed that rTsNas14 could significantly degrade claudin-1. In vivo studies have demonstrated that inhibition of TsNas14 expression significantly impairs the infectivity of T. spiralis in mice, resulting in a decreased AW and muscle larvae burden. These findings suggest that TsNas14 plays a crucial role in T. spiralis intestinal invasion and may serve as a novel potential target for Trichinella vaccines or therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.